New hope for Tough-to-Treat blood cancer: major trial tests promising drug combo
NCT ID NCT07222761
Summary
This large, late-stage study is testing whether new drug treatments can better control multiple myeloma that has come back or stopped responding to prior therapies. It will compare two approaches using an investigational drug called linvoseltamab—given alone or combined with carfilzomib—against current standard treatments. The main goals are to see if these new options lead to deeper, longer-lasting responses with fewer side effects, and to help patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aberdeen Royal Infirmary
RECRUITINGAberdeen, Aberdeenshire, AB25 2ZN, United Kingdom
-
Gold Coast Hospital and Health Service
RECRUITINGSouthport, Queensland, 4215, Australia
-
Ninewells Hospital and Medical School
RECRUITINGDundee, DD1 9SY, United Kingdom
-
Norfolk and Norwich University Hospital National Health Service (NHS) Foundation Trust
RECRUITINGNorwich, Norfolk, NR4 7UY, United Kingdom
-
Royal Cornwall Hospital National Health Service (NHS) Foundation Trust
RECRUITINGTruro, Cornwall, TR1 3LJ, United Kingdom
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
Severance Hospital; Division of Hematology
RECRUITINGSeoul, 03722, South Korea
-
University Hospitals Plymouth National Health Service (NHS) Foundation Trust - Hematology
RECRUITINGPlymouth, Devon, PL6 8DH, United Kingdom
Conditions
Explore the condition pages connected to this study.